These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 38615304)

  • 1. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
    Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
    Apoptosis; 2024 Aug; 29(7-8):1019-1037. PubMed ID: 38615304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of FSP1: A new strategy for the treatment of tumors (Review).
    Dai Q; Wei X; Zhao J; Zhang D; Luo Y; Yang Y; Xiang Y; Liu X
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin Induces Ferroptosis in A549 CD133
    Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M
    Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis inhibitor alleviates sorafenib-induced cardiotoxicity by attenuating KLF11-mediated FSP1-dependent ferroptosis.
    Li Y; Yan J; Sun H; Liang Y; Zhao Q; Yu S; Zhang Y
    Int J Biol Sci; 2024; 20(7):2622-2639. PubMed ID: 38725840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of FSP1-CoQ
    Yang M; Tsui MG; Tsang JKW; Goit RK; Yao KM; So KF; Lam WC; Lo ACY
    Cell Death Dis; 2022 May; 13(5):468. PubMed ID: 35585057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism.
    Miao H; Meng H; Zhang Y; Chen T; Zhang L; Cheng W
    Cell Death Differ; 2024 Apr; 31(4):497-510. PubMed ID: 38374229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Membrane-Targeting Type I/II Photodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis-Enhanced Photodynamic Immunotherapy.
    Chen J; Duan Z; Deng L; Li L; Li Q; Qu J; Li X; Liu R
    Adv Healthc Mater; 2024 Jun; 13(16):e2304436. PubMed ID: 38335308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review.
    Liu M; Kong XY; Yao Y; Wang XA; Yang W; Wu H; Li S; Ding JW; Yang J
    Ann Transl Med; 2022 Mar; 10(6):368. PubMed ID: 35434035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2/FSP1/CoQ10 axis-mediated ferroptosis is involved in sodium aescinate-induced nephrotoxicity.
    Zhu H; Yang Y; Duan Y; Zheng X; Lin Z; Zhou J
    Arch Biochem Biophys; 2024 Sep; 759():110100. PubMed ID: 39033970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
    Mishima E; Ito J; Wu Z; Nakamura T; Wahida A; Doll S; Tonnus W; Nepachalovich P; Eggenhofer E; Aldrovandi M; Henkelmann B; Yamada KI; Wanninger J; Zilka O; Sato E; Feederle R; Hass D; Maida A; Mourão ASD; Linkermann A; Geissler EK; Nakagawa K; Abe T; Fedorova M; Proneth B; Pratt DA; Conrad M
    Nature; 2022 Aug; 608(7924):778-783. PubMed ID: 35922516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
    Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
    Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-targeted liposomal coenzyme Q10 attenuates neuronal ferroptosis after subarachnoid hemorrhage by activating the ferroptosis suppressor protein 1/coenzyme Q10 system.
    Peng Z; Ding YN; Yang ZM; Li XJ; Zhuang Z; Lu Y; Tang QS; Hang CH; Li W
    Acta Biomater; 2024 Apr; 179():325-339. PubMed ID: 38561074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FSP1: a key regulator of ferroptosis.
    Li W; Liang L; Liu S; Yi H; Zhou Y
    Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
    Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
    Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes.
    Liu Y; Cheng D; Wang Y; Xi S; Wang T; Sun W; Li G; Ma D; Zhou S; Li Z; Ni C
    Cell Death Dis; 2022 Dec; 13(12):1070. PubMed ID: 36566325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
    Song Z; Jia G; Ma P; Cang S
    Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.